1-Benzyl-1,4-diazepan-5-one - Names and Identifiers
Name | 1-Benzyl-1,4-diazepan-5-one
|
Synonyms | NSC45105 1-Benzyl-1,4-diazepan-5-one 1-Benzylhomopiperazin-5-one 1-Benzyl-1,4-diazepin-5-one 1-Benzyl-[1,4]diazepan-5-one 1-Benzyl-5-oxo-1,4-diazepane 1-(phenylmethyl)-1,4-diazepan-5-one 5H-1,4-Diazepin-5-one, hexahydro-1-(phenylmethyl)- 1-Benzyl-2,3,6,7-tetrahydro-(1H)-1,4-diazepin-5(4H)-one
|
CAS | 55186-89-5
|
InChI | InChI=1/C12H16N2O/c15-12-6-8-14(9-7-13-12)10-11-4-2-1-3-5-11/h1-5H,6-10H2,(H,13,15) |
1-Benzyl-1,4-diazepan-5-one - Physico-chemical Properties
Molecular Formula | C12H16N2O
|
Molar Mass | 204.27 |
Density | 1.097±0.06 g/cm3(Predicted) |
Melting Point | 115-117° |
Boling Point | 379.8±35.0 °C(Predicted) |
Flash Point | 183.507°C |
Vapor Presure | 0mmHg at 25°C |
pKa | 16.00±0.20(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.55 |
1-Benzyl-1,4-diazepan-5-one - Introduction
1-Benzyl-1,4-diazepan-5-one is an organic compound containing a benzyl group and a 1,4-diazepyl group in its chemical structure, and a ketone group at the 5th position.
Properties of the compound include:
1. appearance: common white crystal or solid.
2. Solubility: Soluble in many organic solvents, such as chloroform, methanol and ethanol, but insoluble in water.
1-Benzyl-1,4-diazepan-5-one has certain applications in the field of medicine:
1. Anxiolytics: The compound is used as a drug for the treatment of anxiety and sleep disorders.
Preparation Method:
1-Benzyl-1,4-diazepan-5-one can be obtained by the reaction of dioxane (1,4,7,10-tetraoxabicyclotetradecanoic acid anhydride) and benzylamine. During the reaction, nucleophilic substitution of benzylamine and dioxane occurs to generate the target product.
Regarding safety information, due to the different regulations and standards in each country and region, it is recommended to consult the relevant official literature or professional bodies for detailed safety information and operating guidelines before using or handling the compound.
Last Update:2024-04-09 18:58:34